Skip to main content

Table 5 Description of drug toxicities occurring during the first year of HAART

From: Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme

Description

Week 0–16

Week 16–32

Week 32–48

Total

Any toxicity

2

2

7

11

EFV hypersensitivity reaction

2

***

1

3

Peripheral neuropathy

***

2

***

2

Elevated transaminases

***

***

1

1

Hyperlactataemia/lactic acidosis

***

***

5

5